Retinal vein occlusion is associated with increased levels of vascular endothelial growth factor; antivascular endothelial growth factor therapy has been proposed as a promising strategy for retinal vein occlusion [29]. The gene discussed is VEGFA; the disease is retinal vein occlusion.